Who Paid My Doc
Jonathan Foote
Gynecologic Oncology Charleston, SC Medical Doctor
NPI 1477781334 CMS profile 1088623
171 Ashley Ave, Charleston, SC 29425
General payments
$3,288
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Jonathan Foote of Charleston, SC is reported in the CMS Open Payments database as having received $3,288 across 134 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 63rd percentile of Gynecologic Oncology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $156 | 6 | |
| 2024 | General | $144 | 3 | |
| 2023 | General | $494 | 21 | |
| 2022 | General | $571 | 28 | |
| 2021 | General | $554 | 27 | |
| 2020 | General | $523 | 23 | |
| 2019 | General | $847 | 26 |
Beside peers
- Jonathan Foote
- Gynecologic Oncology median
- Middle half of Gynecologic Oncology
- National median
In program year 2025, general payments to Jonathan Foote were reported at $156. Among 1,179 Gynecologic Oncology profiles paid that year, the median was $305 and the middle half received between $111 and $1,499.
Show as a table
| Year | Jonathan Foote | Gynecologic Oncology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $847 | $287 | $113–$1,548 | $163 |
| 2020 | $523 | $223 | $59–$2,164 | $114 |
| 2021 | $554 | $193 | $68–$1,139 | $132 |
| 2022 | $571 | $252 | $90–$1,151 | $149 |
| 2023 | $494 | $281 | $102–$1,419 | $160 |
| 2024 | $144 | $308 | $108–$1,502 | $164 |
| 2025 | $156 | $305 | $111–$1,499 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 8 drugsPart D claims
170
Drug cost
$353,890
Branded share of claims
51.8%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Lynparza Olaparib | Brand | 36 | $350,882 | |
| Clobetasol Propionate | Generic | 13 | $925 | |
| Dexamethasone | Generic | 27 | $607 | |
| Imiquimod | Generic | 13 | $533 | |
| Ondansetron Odt Ondansetron | Brand | 34 | $448 | |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | Brand | 18 | $218 | |
| Gabapentin | Generic | 16 | $150 | |
| Megestrol Acetate | Generic | 13 | $127 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 24,311 Part D prescribers listed as Obstetrics & Gynecology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 29 billing codesPaid by Medicare
$27,673
Medicare patients
163
Services billed
399
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 72% | |
| Cancer | 54% | |
| Arthritis | 43% | |
| Diabetes | 31% | |
| Chronic kidney disease | 29% | |
| Ischemic heart disease | 17% | |
| Depression | 15% | |
| Osteoporosis | 13% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
134 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Gynecologic Oncology in South Carolina
Whitney Graybill
Gynecologic Oncology · Charleston, SC
William Merritt
Gynecologic Oncology · Columbia, SC
Mark Miller
Gynecologic Oncology · West Columbia, SC
James Williams
Gynecologic Oncology · Columbia, SC
Courtney Bailey
Gynecologic Oncology · Charleston, SC
Catherine Watson
Gynecologic Oncology · Charleston, SC
Related records
Gynecologic Oncology in South Carolina
Practitioners in the same specialty and state, ranked by reported value.
All Gynecologic Oncology
Everyone recorded under this specialty, nationwide.
Doctors in South Carolina
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.